tiprankstipranks
Armata Pharmaceuticals Inc (DE:TG1N)
STUTTGART:TG1N
Germany Market
TG1N
Armata Pharmaceuticals
RESEARCH TOOLSreports

Armata Pharmaceuticals (TG1N) Income Statement

1 Followers

Armata Pharmaceuticals Income Statement

Last quarter (Q4 2025), Armata Pharmaceuticals's total revenue was $1.08M, a decrease of -12.15% from the same quarter last year. In Q4, Armata Pharmaceuticals's net income was $-124.30M. See Armata Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 4.90M$ 5.17M$ 4.53M$ 5.51M$ 4.47M
Gross Profit
$ 3.37M$ -29.25M$ 3.56M$ -29.51M$ -15.54M
Operating Expenses
$ 34.59M$ 13.18M$ 44.45M$ 7.44M$ 8.28M
Depreciation and Amortization
$ 1.53M$ 1.32M$ 972.00K$ 892.00K$ 1.17M
EBITDA
$ -29.69M$ -41.11M$ -65.45M$ -36.05M$ -21.92M
Operating Income
$ -31.22M$ -42.44M$ -40.89M$ -36.95M$ -23.82M
Other Income/Expenses
$ -142.58M$ 23.52M$ -28.16M$ 29.00K$ 667.00K
Pretax Income
$ -173.80M$ -18.92M$ -69.05M$ -36.92M$ -23.16M
Net Income
$ -173.80M$ -18.92M$ -69.05M$ -36.92M$ -23.16M
Per Share Metrics
Basic EPS
$ -4.80$ -0.52$ -1.91$ -1.08$ -0.96
Diluted EPS
$ -4.80$ -0.52$ -1.91$ -1.08$ -0.96
Weighted Average Shares Outstanding
 36.24M 36.16M 36.08M 34.29M 24.10M
Weighted Average Shares Outstanding (Diluted)
 36.24M 36.16M 36.08M 34.29M 24.10M
Currency in USD

Armata Pharmaceuticals Earnings and Revenue History